The Quantellect read.As of Nov 19, 2026, 5 active firms cover Ingredion Incorporated: 1 rate it Buy or better, 4 sit at Neutral, and 0 rate it Sell or worse, a neutral consensus. Targets are tightly clustered, $104.00 to $130.00, so the covering firms are broadly aligned. The average target of $119.00 sits 32% above the current $89.93. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $2.24 next quarter toward $10.31 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 active firms
Neutral
Strong Buy00%
Buy120%
Neutral480%
Sell00%
Strong Sell00%
Based on 5 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$119.00
+32.3% upside
Average target across 5 active firms as of Nov 19, 2026 vs $89.93 current
Highest Target$130.00
Average Target$119.00
Lowest Target$104.00
Detailed analyst forecasts for INGR
Showing 1–5 of 5 named analysts shown · 5 active firms in the rating projection
As of Nov 19, 2026, 1 of 5 active firms rate INGR a Buy (4 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
INGR EPS & revenue forecast
EPS · NEXT QUARTER
$2.24
Range $2.17 – $2.38 · 3 analysts · -4% YoY
Next period, 3 analysts expect Ingredion Incorporated to earn $2.24 a share (range $2.17 – $2.38), versus $2.34 a year earlier. Full-year consensus is $9.55, growing to $10.31 the year after.
REVENUE · NEXT QUARTER
$1.8B
Range $1.7B – $1.8B · 3 analysts · +0% YoY
Revenue is expected to reach $1.8B (range $1.7B – $1.8B), +0.1% year-over-year. Full-year consensus is $7.2B, rising to $7.3B next year.
Top analysts covering Ingredion Incorporated
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on INGR.
#1
Joshua Spector
UBS · Rank #56
Neutral
$104.00+15.6% to target
Overall win rate
50%
+ Follow
#2
Benjamin Theurer
Barclays · Rank #209
Neutral
$115.00+27.9% to target
Overall win rate
45%
+ Follow
#3
Kristen Owen
Oppenheimer · Rank #422
Neutral
$99.98+11.2% to target
Overall win rate
27%
+ Follow
#4
Andrew Strelzik
BMO Capital · Rank #469
Neutral
$123.00+36.8% to target
Overall win rate
36%
+ Follow
#5
BK
Ben Klieve
Benchmark Co.
Buy
$130.00+44.6% to target
Coverage
—
+ Follow
INGR stock forecast FAQ
What is INGR's average 12-month price target?+
The 5 active firms with a live target average $119.00 for Ingredion Incorporated over the next 12 months, ranging from a $130.00 high to a $104.00 low, as of Nov 19, 2026.
Is INGR stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 5 active firms as of Nov 19, 2026, 1 rate it Buy or Strong Buy, 4 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for INGR?+
The Street-high target is $130.00 (Benchmark), and the Street-low is $104.00 (UBS). The average of all 5 active-firm targets is $119.00.
How many active Wall Street firms cover INGR?+
5 active firms have a recognized rating on Ingredion Incorporated as of Nov 19, 2026, and 5 active firms carry a live 12-month price target.
Who is the most accurate analyst covering INGR?+
Among analysts who currently cover INGR, Joshua Spector of UBS has the strongest overall Quantellect track record (Rank #56). Their current call is Neutral with a $104.00 target.
What is Ingredion Incorporated's projected EPS for next quarter?+
The consensus estimate is $2.24 per share (range $2.17 – $2.38) across 3 analysts. Full-year EPS is projected at $9.55, rising to $10.31 the following year.
How much revenue is Ingredion Incorporated expected to report next quarter?+
Consensus revenue is $1.8B (range $1.7B – $1.8B). Full-year revenue is projected at $7.2B, growing to $7.3B next year.
Have analysts been upgrading or downgrading INGR lately?+
As of Nov 19, 2026, 1 of 5 active firms rate INGR a Buy (4 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their INGR calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.